logo

For the Inventor, By the Inventor

Nes Ziona, Israel

Biokine Therapeutics Ltd.

Calculating rank
USPTO Granted Patents = 35

% Expired Patents = 22.9



Forward Citations = 197

Loading Chart...
Loading Chart...

14 inventors (with patents filed for the assignee):

goldMedal Amnon Peled (29 out of 38 patents)

silverMedal Yaron Pereg (13 out of 14 patents)

bronzeMedal Orly Eizenberg (10 out of 14 patents)

4.  Michal Abraham (8 out of 8 patents)

5.  Nobutaka Fujii (6 out of 19 patents)

6.  Dalit Vaizel-Ohayon (4 out of 4 patents)

7.  Michal Begin (3 out of 3 patents)

8.  Katia Beider (3 out of 3 patents)

9.  Hirokazu Tamamura (3 out of 3 patents)

10.  Akira Hori (3 out of 3 patents)

11.  Efrat Halbfinger (2 out of 5 patents)

12.  Ella Sorani (2 out of 3 patents)

13.  Michal Abraham Karni (1 out of 5 patents)

14.  Ori Wald (1 out of 1 patent)

15.  Shiri Klein Silberman (0 patent)


Core Competencies:
BL-8040
Small Molecules
Chemokine Activity
Cancer Treatment
Peptides
Acute Myeloid Leukemia
CXCR4 Antagonist
Hematopoietic Precursor Cells
Immunomodulation
Autoimmunity
Inflammation
Anti-HIV Agent

35 patents:

1. 12268725 - Composition of BL-8040 (2025-04-08),
2. 12257285 - Composition of BL-8040 (2025-03-25),
3. 11648293 - Compositions and methods for treating cancer (2023-05-16),
4. 11642393 - Compositions and methods for treating cancer (2023-05-09),
5. 11638743 - Compositions and methods for treating cancer (2023-05-02),
6. 11638742 - Compositions and methods for treating cancer (2023-05-02),
7. 11612638 - Compositions and methods for treating cancer (2023-03-28),
8. 11607444 - Compositions and methods for treating cancer (2023-03-21),
9. 11596666 - Compositions and methods for treating cancer (2023-03-07),
10. 11590200 - Compositions and methods for treating cancer (2023-02-28),
11. 11559562 - Compositions and methods for treating cancer (2023-01-24),
12. 11534478 - Compositions and methods for treating cancer (2022-12-27),
13. 11129824 - Small molecules for inhibiting chemokine activity and/or cancer cells growth (2021-09-28),
14. 10993985 - Methods of treating acute myeloid leukemia (2021-05-04),
15. 10959979 - Small molecules against cancer (2021-03-30),
Company Overview
Biokine Therapeutics Ltd. is a biotechnology company based in Nes Ziona, Israel, specializing in the development of innovative therapeutics for cancer treatment. The company focuses on harnessing the power of the immune system to create targeted therapies that enhance patient outcomes. With a commitment to advancing medical science, Biokine Therapeutics is engaged in cutting-edge research and development, aiming to address unmet medical needs in oncology through its proprietary technologies and drug candidates.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

35 Patents

#1 in Nes Ziona

#156 in Israel

#19,181 in the World

Nes Ziona, IL
Nes Ziona, Israel

Biokine Therapeutics Ltd.

Forward Citations = 197

14 inventors:

goldMedal Amnon Peled (29 out of 38 patents)

silverMedal Yaron Pereg (13 out of 14 patents)

bronzeMedal Orly Eizenberg (10 out of 14 patents)

4.  Michal Abraham (8 out of 8 patents)

5.  Nobutaka Fujii (6 out of 19 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Biokine Therapeutics Ltd.. Retrieved from https://idiyas.com/company/biokine-therapeutics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…